◆英語タイトル：Can-Fite BioPharma Ltd (CANF) - Financial and Strategic SWOT Analysis Review
Can-Fite BioPharma Ltd (Can-Fite) is a clinical stage drug development Company that strives to develop small molecule drugs for the treatment of cancer and inflammatory diseases. The company’s pipeline products which are in phase II and III clinical development stage includes CF101, for rheumatoid arthritis and psoriasis; CF102, for hepatocellular carcinoma; and CF602, for erectile dysfunction. Can-Fite develops its products by harnessing its technology platform which is based on the Gi protein associates A3 adenosine receptor (A3AR). The company works in collaboration with pharmaceutical and biotechnology companies to develop its product portfolio. It has operations in Israel and the US. Can-Fite is headquartered in Petah-Tikva, Israel.
Can-Fite BioPharma Ltd Key Recent Developments
Feb 27,2019: Can-Fite to participate in Bio Asia International Conference on March 5-6, 2019 in Tokyo
Feb 27,2019: Feb 27, 2019 7:00 AM EST Can-Fite to Participate in Bio Asia International Conference on March 5-6, 2019 in Tokyo
Jan 24,2019: Can-Fite BioPharma CEO Letter to Shareholders
This comprehensive SWOT profile of Can-Fite BioPharma Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Can-Fite BioPharma Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Can-Fite BioPharma Ltd – Key Information
Can-Fite BioPharma Ltd – Overview
Can-Fite BioPharma Ltd – Key Employees
Can-Fite BioPharma Ltd – Key Employee Biographies
Can-Fite BioPharma Ltd – Key Operational Heads
Can-Fite BioPharma Ltd – Major Products and Services
Can-Fite BioPharma Ltd – History
Can-Fite BioPharma Ltd – Company Statement
Can-Fite BioPharma Ltd – Locations And Subsidiaries
Can-Fite BioPharma Ltd – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
Can-Fite BioPharma Ltd – Business Description
Can-Fite BioPharma Ltd – Corporate Strategy
Can-Fite BioPharma Ltd – SWOT Analysis
SWOT Analysis – Overview
Can-Fite BioPharma Ltd – Strengths
Can-Fite BioPharma Ltd – Weaknesses
Can-Fite BioPharma Ltd – Opportunities
Can-Fite BioPharma Ltd – Threats
Can-Fite BioPharma Ltd – Key Competitors
Section 3 – Company Financial Performance Charts
Can-Fite BioPharma Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Can-Fite BioPharma Ltd, Key Information
Can-Fite BioPharma Ltd, Key Ratios
Can-Fite BioPharma Ltd, Share Data
Can-Fite BioPharma Ltd, Major Products and Services
Can-Fite BioPharma Ltd, History
Can-Fite BioPharma Ltd, Key Employees
Can-Fite BioPharma Ltd, Key Employee Biographies
Can-Fite BioPharma Ltd, Key Operational Heads
Can-Fite BioPharma Ltd, Other Locations
Can-Fite BioPharma Ltd, Subsidiaries
Can-Fite BioPharma Ltd, Key Manufacturing facilities
Can-Fite BioPharma Ltd, Key Competitors
Can-Fite BioPharma Ltd, SWOT Analysis
Can-Fite BioPharma Ltd, Ratios based on current share price
Can-Fite BioPharma Ltd, Annual Ratios
Can-Fite BioPharma Ltd, Interim Ratios
Capital Market Ratios
List of Figures
Can-Fite BioPharma Ltd, Performance Chart
Can-Fite BioPharma Ltd, Ratio Charts
| ★海外企業調査レポート[Can-Fite BioPharma Ltd (CANF)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら